WuXi CFO Edward Hu to Discuss VC Funding at BIO China

WuXi CFO Edward Hu will share his thoughts on early-stage venture capital funding at BIO China in November. As head of WuXi Corporate Venture Fund, Hu pays close attention to the...

WuXi SVP Chris Chen to Deliver Keynote Speech at IBC’s BioProcess International China...

WuXi  executive Dr. Chris Chen is to deliver the keynote speech at IBC’s BioProcess  International China Conference in August. Chen, Senior Vice President  and Chief Technology Officer, Biologics Services at WuXi,...

WuXi Global Webinar – “Demystifying Product Development in China”

Overview China’s fast growing healthcare market represents a significant opportunity for pharmaceutical and biotechnology companies to develop and launch therapies. By capitalizing on local research, development, manufacturing, and regulatory know-how, companies can design and...

WuXi Global Forum – “Gateway to China” during JP Morgan Conference 2013

January 8, 2013 | Grand Hyatt San Francisco China is the world’s 3rd largest pharmaceutical market, 2nd largest economy, and 1st largest population with huge unmet medical needs. This special forum hosted...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi NextCODE Completes $240 Million Series B Financing

We are pleased to announce that WuXi NextCODE has successfully completed a $240 million Series B financing. The company extended and completed the Series...